You have 9 free searches left this month | for more free features.

Condition

Focal Segmental Glomerulosclerosis (1)

Insulin Sensitivity (1)

Minimal Change Disease (1)

Nephrotic Syndrome (1)

Renal Colic (1)

Septic Shock (1)

Overall Status

Completed (3)

Terminated (1)

Sign in for free

Phase

phase 2 (2)

n/a (1)

phase 1/phase 2 (1)

Sponsor

Beth Israel Deaconess Medical Center (1)

Bristol-Myers Squibb (1)

Henry Ford Health System (1)

The University of Texas Health Science Center at San Antonio (1)

Collaborator

National Center for Complementary and Integrative Health (NCCIH) (1)

National Institutes of Health (NIH) (1)

Intervention

d5w (4)

abatacept (1)

eritoran (1)

magnesium sulfate (1)

normal saline (1)

thiamine (1)

Study Documents

Intervention Type

drug (4)

other (1)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (4)

d5w

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Insulin Sensitivity Trial in San Antonio (Eritoran, D5W)

Terminated

Has Results

Insulin Sensitivity

Eritoran
D5W

San Antonio, Texas

Audie L. Murphy VA Hospital, STVHCS

Feb 24, 2020

Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change Disease Trial in United States (Abatacept, Normal Saline,

Completed

Has Results

Nephrotic Syndrome
+2 more

Abatacept
+2 more

Birmingham, Alabama
+26 more

Feb 10, 2021

Renal Colic Trial (Magnesium Sulfate, D5W)

Completed

Renal Colic

Magnesium Sulfate
D5W

(no location specified)

Aug 3, 2018

Septic Shock Trial in Boston (D5W, Thiamine)

Completed

Has Results

Septic Shock

D5W
Thiamine

Boston, Massachusetts

Beth Israel Deaconess Medical Center

Apr 29, 2017